Search

Your search keyword '"Serrero, Mélanie"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Serrero, Mélanie" Remove constraint Author: "Serrero, Mélanie"
145 results on '"Serrero, Mélanie"'

Search Results

1. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

2. Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID

3. Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe dʼEtude Thérapeutique des Affections Inflammatoires du Tube Digestif

4. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

5. Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

6. Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under biologics: A Prospective, Multicenter, Observational, One-Year follow-up comparative study

7. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

8. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn’s disease

9. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study

10. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

11. Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent.

12. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

13. Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus

14. Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

16. Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID

17. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

18. The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics

19. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID

20. Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID

21. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

22. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

23. Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study

24. Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.

25. Mo1565: EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH CHRONIC ACTIVE POUCHITIS REFRACTORY TO ANTI-TNF THERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

26. Su1503: REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT

27. Su1490: COVID-19: A PREVALENCE RATE TWO TIMES LOWER THAN THAT OF THE GENERAL POPULATION IN FRENCH PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INTRAVENOUS BIOLOGIC AGENTS

29. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

32. Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study

33. Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus.

34. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

35. Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.

36. Ustekinumab for Perianal Crohn's Disease

37. sj-pdf-1-ueg-10.1177_2050640620950093 - Supplemental material for Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials

38. ENDOSCOPIC SUBMUCOSAL DISSECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS FOR VISIBLE DYSPLASIA: A FRENCH RETROSPECTIVE MULTICENTRIC STUDY

39. Sa1820 RISK OF INCIDENT CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WITH PRIOR BREAST CANCER : A MULTICENTRE COHORT STUDY

42. Recommandations de pratique pour le diagnostic et la prise en charge de la rectocolite hémorragique (version courte).

44. Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY

48. Endoscopic ultra-sound (EUS) guided management of symptomatic pelvic collections: puncture-aspiration or drainage? Results from mono-centric retrospective experience with therapeutic algorithm.

49. Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.

Catalog

Books, media, physical & digital resources